Skip to main content
Erschienen in: The European Journal of Health Economics 4/2011

01.08.2011 | Original Paper

Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges

verfasst von: Raymond Oppong, Joanna Coast, Kerry Hood, Jacqui Nuttall, Richard D. Smith, Christopher C. Butler

Erschienen in: The European Journal of Health Economics | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The objectives of this study were to estimate the resource use and cost of treating acute cough/lower respiratory tract infection (acute cough/LRTI) in 13 European countries, to explore reasons for differences in cost and to document the challenges that researchers face when collecting information on cost alongside multinational studies. Data on resource use and cost were collected alongside an observational study in 14 primary care networks across 13 European countries and a mean cost was generated for each network. The results show that the mean cost (standard deviation) of treating acute cough/LRTI in Europe ranged from €23.88 (34.67) in Balatonfüred (Hungary) to €116.47 (34.29) in Jonkoping (Sweden). The observed differences in costs were statistically significant (P < 0.01). Major cost drivers include general practitioner visits and drug costs in all networks, whilst differences in health systems and regional factors could account for differences in cost between networks. The major barrier to conducting multinational cost studies are barriers associated with identifying cost information.
Literatur
1.
Zurück zum Zitat Ball, P., et al.: Antibiotic therapy of community acquired lower respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J. Antimicrob. Chemother. 49, 31–40 (2002)PubMedCrossRef Ball, P., et al.: Antibiotic therapy of community acquired lower respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J. Antimicrob. Chemother. 49, 31–40 (2002)PubMedCrossRef
2.
Zurück zum Zitat Ortqvist, A.: Treatment of community acquired lower respiratory tract infections in adults. Eur. Respir. J. 20(Suppl 36), 40S–53S (2002)CrossRef Ortqvist, A.: Treatment of community acquired lower respiratory tract infections in adults. Eur. Respir. J. 20(Suppl 36), 40S–53S (2002)CrossRef
3.
Zurück zum Zitat Ehlke, B., et al.: Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur. J. Pediatr. 164(10), 607–615 (2005)CrossRef Ehlke, B., et al.: Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur. J. Pediatr. 164(10), 607–615 (2005)CrossRef
4.
Zurück zum Zitat Guest, J.F., Morris, A.: Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur. Respir. J. 10, 1530–1534 (1997) Guest, J.F., Morris, A.: Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur. Respir. J. 10, 1530–1534 (1997)
5.
Zurück zum Zitat Guthrie, R.: Community acquired lower respiratory tract infections: etiology and treatment. Chest 120, 2021–2034 (2001)PubMedCrossRef Guthrie, R.: Community acquired lower respiratory tract infections: etiology and treatment. Chest 120, 2021–2034 (2001)PubMedCrossRef
7.
Zurück zum Zitat Hak, E., et al.: Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care. Fam. Pract. 22, 375–380 (2005)PubMedCrossRef Hak, E., et al.: Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care. Fam. Pract. 22, 375–380 (2005)PubMedCrossRef
8.
Zurück zum Zitat Cals, J.W.L., et al.: Improving management of patients with acute cough by C-reactive protein point of care testing and community training (IMPACT): study protocol of a cluster randomised controlled trial. BMC Fam. Pract. 8, 15 (2007)PubMedCrossRef Cals, J.W.L., et al.: Improving management of patients with acute cough by C-reactive protein point of care testing and community training (IMPACT): study protocol of a cluster randomised controlled trial. BMC Fam. Pract. 8, 15 (2007)PubMedCrossRef
9.
Zurück zum Zitat Gjelstad, S., et al.: Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice—the prescribing peer academic detailing study. BMC Health Serv. Res. 6, 75 (2006)PubMedCrossRef Gjelstad, S., et al.: Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice—the prescribing peer academic detailing study. BMC Health Serv. Res. 6, 75 (2006)PubMedCrossRef
10.
Zurück zum Zitat Goosens, H., et al.: National campaigns to improve antibiotic use. Eur. J. Clin. Pharmacol. 62, 373–379 (2006)CrossRef Goosens, H., et al.: National campaigns to improve antibiotic use. Eur. J. Clin. Pharmacol. 62, 373–379 (2006)CrossRef
11.
Zurück zum Zitat Coenen, S., et al.: Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial. J. Antimicrob. Chemother. 54, 661–672 (2004)PubMedCrossRef Coenen, S., et al.: Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial. J. Antimicrob. Chemother. 54, 661–672 (2004)PubMedCrossRef
12.
Zurück zum Zitat Van Driel, M.L., et al.: What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary care. Qual. Saf. Health Care 16, 197–202 (2007)PubMedCrossRef Van Driel, M.L., et al.: What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary care. Qual. Saf. Health Care 16, 197–202 (2007)PubMedCrossRef
13.
Zurück zum Zitat Kristinsson, K.G.: Effects of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb. Drug Resist. 3, 117–123 (1997)PubMedCrossRef Kristinsson, K.G.: Effects of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb. Drug Resist. 3, 117–123 (1997)PubMedCrossRef
14.
Zurück zum Zitat Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M.M., Huber, P.R., Tamm, M., Muller, B.: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections. Cluster randomised, single blinded intervention trial. Lancet 363, 600–607 (2004)PubMedCrossRef Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M.M., Huber, P.R., Tamm, M., Muller, B.: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections. Cluster randomised, single blinded intervention trial. Lancet 363, 600–607 (2004)PubMedCrossRef
15.
Zurück zum Zitat Manca, A., et al.: Assessing the generalizability by location in trial based cost-effectiveness analysis: the use of multilevel models. Health Econ. 14, 471–485 (2005)PubMedCrossRef Manca, A., et al.: Assessing the generalizability by location in trial based cost-effectiveness analysis: the use of multilevel models. Health Econ. 14, 471–485 (2005)PubMedCrossRef
16.
Zurück zum Zitat Pang, F.: Design, analysis and presentation of multinational economic studies: the need for guidance. Pharmacoeconomics 20(2), 75–90 (2002)PubMedCrossRef Pang, F.: Design, analysis and presentation of multinational economic studies: the need for guidance. Pharmacoeconomics 20(2), 75–90 (2002)PubMedCrossRef
17.
Zurück zum Zitat Raikou, M., et al.: Centre specific or average unit costs in multinational clinical trials? Some theory and simulation. Health Econ. 9, 191–198 (2000)PubMedCrossRef Raikou, M., et al.: Centre specific or average unit costs in multinational clinical trials? Some theory and simulation. Health Econ. 9, 191–198 (2000)PubMedCrossRef
18.
Zurück zum Zitat Virk, K.P.: Global clinical trials: the challenge of language. Drug Inform. Assoc. 44(4), 21–23 (2008) Virk, K.P.: Global clinical trials: the challenge of language. Drug Inform. Assoc. 44(4), 21–23 (2008)
19.
Zurück zum Zitat Schulman, K., et al.: Resource costing for multinational neurologic clinical trials: methods and results. Health Econ. 7, 629–638 (1998)PubMedCrossRef Schulman, K., et al.: Resource costing for multinational neurologic clinical trials: methods and results. Health Econ. 7, 629–638 (1998)PubMedCrossRef
20.
Zurück zum Zitat Wordsworth, S., et al.: Collecting unit costs data in multicentre studies creating comparable methods European. J. Health Econ. 50, 38–44 (2005) Wordsworth, S., et al.: Collecting unit costs data in multicentre studies creating comparable methods European. J. Health Econ. 50, 38–44 (2005)
21.
Zurück zum Zitat Koopmanscap, M.A., et al.: Analysis of cost and cost-effectiveness in multinational trials. Health Policy 58, 175–186 (2001)CrossRef Koopmanscap, M.A., et al.: Analysis of cost and cost-effectiveness in multinational trials. Health Policy 58, 175–186 (2001)CrossRef
22.
Zurück zum Zitat Butler, C.C., et al.: Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 338, b2242 (2009)PubMedCrossRef Butler, C.C., et al.: Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 338, b2242 (2009)PubMedCrossRef
25.
Zurück zum Zitat Donner, A., Klar, N.: Design and analysis of cluster randomization trials in health research. Hodder Arnold, London (2000) Donner, A., Klar, N.: Design and analysis of cluster randomization trials in health research. Hodder Arnold, London (2000)
26.
Zurück zum Zitat Rurik, I.: Primary care diabetes in Hungary. Prim. Care Diabetes 177–179 (2007) Rurik, I.: Primary care diabetes in Hungary. Prim. Care Diabetes 177–179 (2007)
27.
Zurück zum Zitat Little, P.: Delayed prescribing of antibiotics for upper respiratory tract infection. BMJ 331, 301–302 (2005)PubMedCrossRef Little, P.: Delayed prescribing of antibiotics for upper respiratory tract infection. BMJ 331, 301–302 (2005)PubMedCrossRef
28.
Zurück zum Zitat NICE.: Respiratory tract infections—antibiotic prescribing. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. http://www.nice.org.uk (2008) NICE.: Respiratory tract infections—antibiotic prescribing. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. http://​www.​nice.​org.​uk (2008)
29.
Zurück zum Zitat De Smet, P.: Herbal medicine in Europe—relaxing regulatory standards. N. Engl. J. Med. 352, 1176–1178 (2005)PubMedCrossRef De Smet, P.: Herbal medicine in Europe—relaxing regulatory standards. N. Engl. J. Med. 352, 1176–1178 (2005)PubMedCrossRef
30.
Zurück zum Zitat Goosens, H., et al.: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365, 579–587 (2005) Goosens, H., et al.: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365, 579–587 (2005)
31.
Zurück zum Zitat Grytten, J., Sorensen, R.: Type of contract and supplier—induced demand for primary physicians in Norway. J. Health Econ. 20, 379–393 (2001)PubMedCrossRef Grytten, J., Sorensen, R.: Type of contract and supplier—induced demand for primary physicians in Norway. J. Health Econ. 20, 379–393 (2001)PubMedCrossRef
32.
Zurück zum Zitat Birnbaum, H.G., et al.: Lower respiratory tract infections impact on the workplace. Pharmacoeconomics 21(10), 749–759 (2003)PubMedCrossRef Birnbaum, H.G., et al.: Lower respiratory tract infections impact on the workplace. Pharmacoeconomics 21(10), 749–759 (2003)PubMedCrossRef
33.
Zurück zum Zitat Cook, J.R., et al.: Assessing the appropriateness of combining economic data from multinational clinical trials. Stat. Med. 22, 1955–1976 (2003)PubMedCrossRef Cook, J.R., et al.: Assessing the appropriateness of combining economic data from multinational clinical trials. Stat. Med. 22, 1955–1976 (2003)PubMedCrossRef
34.
Zurück zum Zitat Reed, S.D., et al.: Conducting economic evaluations alongside multinational clinical trials: towards a research consensus. Am. Heart J. 149(3), 434–443 (2005)PubMedCrossRef Reed, S.D., et al.: Conducting economic evaluations alongside multinational clinical trials: towards a research consensus. Am. Heart J. 149(3), 434–443 (2005)PubMedCrossRef
35.
Zurück zum Zitat Epstein, D., et al.: The hospital care for stroke in nine European countries. Health Econ. 17, S21–S31 (2008)PubMedCrossRef Epstein, D., et al.: The hospital care for stroke in nine European countries. Health Econ. 17, S21–S31 (2008)PubMedCrossRef
Metadaten
Titel
Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges
verfasst von
Raymond Oppong
Joanna Coast
Kerry Hood
Jacqui Nuttall
Richard D. Smith
Christopher C. Butler
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
The European Journal of Health Economics / Ausgabe 4/2011
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-010-0239-1

Weitere Artikel der Ausgabe 4/2011

The European Journal of Health Economics 4/2011 Zur Ausgabe